Merck KGaA

M1774 (ATR inhibitor)

Biodrugs/ Drugs
Cancer
DDRiver Solid Tumors 320. ATR inhibitor in combination with Dna Damage Response Inhibitors or Immune Checkpoint Inhibitors
1Phase I in Spain